Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos.
We have recently shown that the dissolution of ZnO nanoparticles and Zn(2+) shedding leads to a series of sublethal and lethal toxicological responses at the cellular level that can be alleviated by iron doping. Iron doping changes the particle matrix and slows the rate of particle dissolution. To determine whether iron doping of ZnO also leads to lesser toxic effects in vivo, toxicity studies were performed in rodent and zebrafish models. First, we synthesized a fresh batch of ZnO nanoparticles doped with 1-10 wt % of Fe. These particles were extensively characterized to confirm their doping status, reduced rate of dissolution in an exposure medium, and reduced toxicity in a cellular screen. Subsequent studies compared the effects of undoped to doped particles in the rat lung, mouse lung, and the zebrafish embryo. The zebrafish studies looked at embryo hatching and mortality rates as well as the generation of morphological defects, while the endpoints in the rodent lung included an assessment of inflammatory cell infiltrates, LDH release, and cytokine levels in the bronchoalveolar lavage fluid. Iron doping, similar to the effect of the metal chelator, DTPA, interfered in the inhibitory effects of Zn(2+) on zebrafish hatching. In the oropharyngeal aspiration model in the mouse, iron doping was associated with decreased polymorphonuclear cell counts and IL-6 mRNA production. Doped particles also elicited decreased heme oxygenase 1 expression in the murine lung. In the intratracheal instillation studies in the rat, Fe doping was associated with decreased polymorphonuclear cell counts, LDH, and albumin levels. All considered, the above data show that Fe doping is a possible safe design strategy for preventing ZnO toxicity in animals and the environment.
Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, California 90095, USA.
Tian
T
Xia
Yan
Y
Zhao
Tina
T
Sager
Saji
S
George
Suman
S
Pokhrel
Ning
N
Li
David
D
Schoenfeld
Huan
H
Meng
Sijie
S
Lin
Xiang
X
Wang
Meiying
M
Wang
Zhaoxia
Z
Ji
Jeffrey I
JI
Zink
Lutz
L
Mädler
Vincent
V
Castranova
Shuo
S
Lin
Andre E
AE
Nel
D000818:Animals; D002460:Cell Line; D004625:Embryo, Nonmammalian / Q000187:drug effects*; D005260:Female; D007249:Inflammation / Q000139:chemically induced; D007501:Iron / Q000737:chemistry*; D008168:Lung / Q000187:drug effects*; D008297:Male; D051379:Mice; D053758:Nanoparticles / Q000737:chemistry / Q000633:toxicity*; D051381:Rats; D018675:Toxicity Tests / Q000379:methods*; D015027:Zebrafish; D015034:Zinc Oxide / Q000737:chemistry*
D007501:Iron; D015034:Zinc Oxide
Toxicol Sci. 2007 Jan;95(1):270-80
17030555
Inhal Toxicol. 2007 Aug;19(10):849-56
17687716
Aquat Toxicol. 2008 Feb 18;86(3):437-46
18243362
Science. 2006 Feb 3;311(5761):622-7
16456071
Toxicol Sci. 2006 Jul;92(1):126-32
16597657
J Occup Environ Med. 1997 Aug;39(8):722-6
9273875
FEBS J. 2008 Dec;275(23):5934-46
19021768
ACS Nano. 2009 Jul 28;3(7):1620-7
21452863
Mol Endocrinol. 2006 Jan;20(1):194-203
16099813
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):979-82
15647362
Toxicol Sci. 2001 Mar;60(1):144-51
11222881
Environ Pollut. 2008 Nov;156(2):233-9
18824285
Environ Health Perspect. 2009 Jul;117(7):1116-23
19654922
Environ Health Perspect. 2005 Feb;113(2):233-41
15687063
Toxicol Appl Pharmacol. 1992 Nov;117(1):75-80
1440616
Nanotechnology. 2009 May 13;20(19):195103
19420631
Nat Rev Drug Discov. 2005 Jan;4(1):35-44
15688071
Integr Environ Assess Manag. 2007 Jan;3(1):3-17
17283592
Toxicology. 2010 Mar 10;269(2-3):105-19
19732804
Clin Pharmacol Ther. 2007 Jul;82(1):70-80
17495877
ACS Nano. 2008 Oct 28;2(10):2121-34
19206459
ACS Nano. 2008 Mar;2(3):395-402
19206562
Nano Lett. 2006 Aug;6(8):1794-807
16895376
Environ Health Perspect. 1997 Sep;105 Suppl 5:1013-20
9400693
Am J Physiol Lung Cell Mol Physiol. 2008 Oct;295(4):L552-65
18658273
ACS Nano. 2010 Jan 26;4(1):15-29
20043640
Environ Sci Technol. 2010 Oct 1;44(19):7309-14
20536146
Toxicol Sci. 2002 Nov;70(1):86-97
12388838
Toxicol Sci. 2007 May;97(1):163-80
17301066
ACS Nano. 2007 Sep;1(2):133-43
19122772
Am J Ind Med. 1999 Jun;35(6):574-80
10332510
Toxicol Sci. 2010 Nov;118(1):140-9
20705894
Occup Med. 1993 Jul-Sep;8(3):504-17
8272976
Methods. 2001 Dec;25(4):402-8
11846609
Respir Res. 2005 Jul 18;6:73
16026622
Am J Respir Cell Mol Biol. 1992 Feb;6(2):235-43
1540387
Adv Drug Deliv Rev. 2009 Jun 21;61(6):478-86
19389433
AMA Arch Ind Health. 1957 Jul;16(1):42-7
13434495
J Mol Biol. 2010 Oct 8;402(5):865-78
20727360
Chemosphere. 2009 Nov;77(7):928-33
19751945
Environ Sci Technol. 2006 Mar 1;40(5):1516-23
16568765